Mek. Kraeling et al., METABOLISM OF BENZOCAINE DURING PERCUTANEOUS-ABSORPTION IN THE HAIRLESS GUINEA-PIG - ACETYLBENZOCAINE FORMATION AND ACTIVITY, Skin pharmacology, 9(3), 1996, pp. 221-230
The effect of dose and enzymatic inhibition on the percutaneous absorp
tion and metabolism of benzocaine was studied in vitro in the hairless
guinea pig, At the dose level of 2 mu g/cm(2), benzocaine was rapidly
absorbed and extensively metabolized (80%) by acetyltransferase. As t
he applied dose of benzocaine was increased to 40 and 200 mu g/cm(2),
N-acetylation of benzocaine decreased to 44 and 34%, respectively, sug
gesting saturation of the acetyltransferase system, Total C-14 absorpt
ion after benzocaine application was not significantly different betwe
en control and enzyme-inhibited skin and therefore does not appear to
be affected by the extent of benzocaine metabolism during percutaneous
penetration, Skin provides a significant first-pass metabolic effect
for therapeutic doses of percutaneously absorbed benzocaine, and the p
rimary metabolite formed, acetylbenzocaine, is biologically active.